ISIN | CH0594527720 |
---|---|
Valor Number | 59452772 |
Bloomberg Global ID | UBPAIIX SW |
Fund Name | UBS (CH) Investment Fund - Equities Switzerland ESG Passive All II I-X-acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland | |
Distributor(s) |
UBS AG Basel Phone: +41 61 288 20 20 |
Asset Class | Bonds |
EFC Category | Equity Switzerland |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | Das Anlageziel dieses Teilvermögens besteht hauptsächlich darin, den repräsentativen Referenzindex SPI® ESG (TR) für den schweizerischen Aktienmarkt (Bench-mark) passiv nachzubilden und eine Performance zu erzielen, welche dessen Entwicklung entspricht. |
Peculiarities |
Current Price * | 1,207.50 CHF | 17.09.2025 |
---|---|---|
Previous Price * | 1,208.69 CHF | 16.09.2025 |
52 Week High * | 1,260.38 CHF | 03.03.2025 |
52 Week Low * | 1,060.82 CHF | 09.04.2025 |
NAV * | 1,207.50 CHF | 17.09.2025 |
Issue Price * | 1,207.50 CHF | 17.09.2025 |
Redemption Price * | 1,207.50 CHF | 17.09.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 2,450,563,979 | |
Unit/Share Assets *** | 1,982,358,844 | |
Trading Information SIX |
YTD Performance | +7.54% |
31.12.2024 - 17.09.2025
31.12.2024 17.09.2025 |
---|---|---|
1 month | -0.44% |
18.08.2025 - 17.09.2025
18.08.2025 17.09.2025 |
3 months | +0.30% |
17.06.2025 - 17.09.2025
17.06.2025 17.09.2025 |
6 months | -3.76% |
17.03.2025 - 17.09.2025
17.03.2025 17.09.2025 |
1 year | +3.74% |
17.09.2024 - 17.09.2025
17.09.2024 17.09.2025 |
2 years | +13.88% |
18.09.2023 - 17.09.2025
18.09.2023 17.09.2025 |
3 years | +23.08% |
19.09.2022 - 17.09.2025
19.09.2022 17.09.2025 |
5 years | +25.26% |
11.02.2021 - 17.09.2025
11.02.2021 17.09.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novartis AG Registered Shares | 12.65% | |
---|---|---|
Nestle SA | 12.37% | |
Roche Holding AG | 11.65% | |
UBS Group AG Registered Shares | 6.20% | |
Zurich Insurance Group AG | 5.45% | |
ABB Ltd | 5.40% | |
Compagnie Financiere Richemont SA Class A | 4.78% | |
Swiss Re AG | 2.72% | |
Lonza Group Ltd | 2.61% | |
Holcim Ltd | 2.31% | |
Last data update | 31.08.2025 |
TER | 0.01% |
---|---|
TER date | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | |
Ongoing Charges *** | 0.01% |
SRRI ***
|
|
SRRI date *** | 31.08.2025 |